208 related articles for article (PubMed ID: 14680482)
1. Models of breast cancer: is merging human and animal models the future?
Kim JB; O'Hare MJ; Stein R
Breast Cancer Res; 2004; 6(1):22-30. PubMed ID: 14680482
[TBL] [Abstract][Full Text] [Related]
2. mTORC1/2 targeted by n-3 polyunsaturated fatty acids in the prevention of mammary tumorigenesis and tumor progression.
Chen Z; Zhang Y; Jia C; Wang Y; Lai P; Zhou X; Wang Y; Song Q; Lin J; Ren Z; Gao Q; Zhao Z; Zheng H; Wan Z; Gao T; Zhao A; Dai Y; Bai X
Oncogene; 2014 Sep; 33(37):4548-57. PubMed ID: 24096482
[TBL] [Abstract][Full Text] [Related]
3. [Establishment of a whole-body visualization model of breast cancer with high hepatic metastatic potential in nude mice through serial passage in vivo].
Yang M; Yang ZH; Hou ZD; Li XN
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):944-7. PubMed ID: 18583234
[TBL] [Abstract][Full Text] [Related]
4. Regulation of zinc transporters by dietary zinc supplement in breast cancer.
Sun D; Zhang L; Wang Y; Wang X; Hu X; Cui FA; Kong F
Mol Biol Rep; 2007 Dec; 34(4):241-7. PubMed ID: 17473989
[TBL] [Abstract][Full Text] [Related]
5. Mouse models for breast cancer.
Hennighausen L
Oncogene; 2000 Feb; 19(8):966-7. PubMed ID: 10713679
[No Abstract] [Full Text] [Related]
6. Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model.
Frandsen TL; Holst-Hansen C; Nielsen BS; Christensen IJ; Nyengaard JR; Carmeliet P; Brünner N
Cancer Res; 2001 Jan; 61(2):532-7. PubMed ID: 11212246
[TBL] [Abstract][Full Text] [Related]
7. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
8. Special considerations in mouse models of breast cancer.
Borowsky A
Breast Dis; 2007; 28():29-38. PubMed ID: 18057541
[No Abstract] [Full Text] [Related]
9. Models of breast cancer: quo vadis, animal modeling?
Wagner KU
Breast Cancer Res; 2004; 6(1):31-8. PubMed ID: 14680483
[TBL] [Abstract][Full Text] [Related]
10. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.
Pan Q; Kleer CG; van Golen KL; Irani J; Bottema KM; Bias C; De Carvalho M; Mesri EA; Robins DM; Dick RD; Brewer GJ; Merajver SD
Cancer Res; 2002 Sep; 62(17):4854-9. PubMed ID: 12208730
[TBL] [Abstract][Full Text] [Related]
11. [Genistein exerts multiple suppressive effects on human breast carcinoma cells].
Shao Z; Wu J; Shen Z
Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):362-5. PubMed ID: 11778268
[TBL] [Abstract][Full Text] [Related]
12. Clinically relevant metastatic breast cancer models to study chemosensitivity.
Kim LS; Price JE
Methods Mol Med; 2005; 111():285-95. PubMed ID: 15911986
[TBL] [Abstract][Full Text] [Related]
13. A novel orthotopic and metastatic mouse model of breast cancer in human mammary microenvironment.
Wang J; Xia TS; Liu XA; Ding Q; Du Q; Yin H; Wang S
Breast Cancer Res Treat; 2010 Apr; 120(2):337-44. PubMed ID: 19350386
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor alpha and mouse models of human breast cancer.
Humphreys RC; Hennighausen L
Oncogene; 2000 Feb; 19(8):1085-91. PubMed ID: 10713694
[TBL] [Abstract][Full Text] [Related]
16. Contributions of mouse biology to breast cancer research.
Cardiff RD; Bern HA; Faulkin LJ; Daniel CW; Smith GH; Young LJ; Medina D; Gardner MB; Wellings SR; Shyamala G; Guzman RC; Rajkumar L; Yang J; Thordarson G; Nandi S; MacLeod CL; Oshima RG; Man AK; Sawai ET; Gregg JP; Cheung AT; Lau DH
Comp Med; 2002 Feb; 52(1):12-31. PubMed ID: 11900409
[No Abstract] [Full Text] [Related]
17. Human breast carcinoma xenografts in nude mice.
Li Z; Huang X; Li J; Ke Y; Yang L; Wang Y; Yao L; Lu Y
Chin Med J (Engl); 2002 Feb; 115(2):222-6. PubMed ID: 11940336
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between antitumor effects against human mammary carcinoma (MX-1) in nude mice and clinical efficacy of human breast cancer in thirty-four antitumor agents].
Inoue K; Fujimoto S; Ogawa M
Nihon Gan Chiryo Gakkai Shi; 1983 Feb; 18(1):13-20. PubMed ID: 6864045
[No Abstract] [Full Text] [Related]
19. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
[TBL] [Abstract][Full Text] [Related]
20. Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90.
Mehta PP; Whalen P; Baxi SM; Kung PP; Yamazaki S; Yin MJ
Clin Cancer Res; 2011 Aug; 17(16):5432-42. PubMed ID: 21715568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
